Science and Research Content

Elsevier acquires Via Oncology, a clinical decision support solutions provider for oncology professionals -

Elsevier, the information analytics business specializing in science and health, and part of RELX Group, has acquired Via Oncology, a Pittsburgh, Pennsylvania-based company that provides decision support and best practices in cancer care management. A former subsidiary of UPMC, one of the nation's leading integrated healthcare delivery and financing systems, Via Oncology helps cancer centers demonstrate the value of their care to patients, referring physicians and payers by developing and implementing clinical pathways in collaboration with its network of more than 1,500 US cancer care providers.

Via Oncology's Via Pathways is evidence-based proprietary content developed by committees composed of leading oncologists that forms the basis of clinical algorithms covering 95 percent of cancer types treated in the US. This content is deployed to physicians and their staff at the point of care through the Via Portal, a patient-specific decision support tool that is integrated with the electronic medical record and provides seamless measurement of adherence.

Via Pathways addresses more than 2,000 unique patient presentations, including expert-defined clinical algorithms and specific recommendations for all significant aspects of cancer care. Additional services provide nurse triage and tracking of symptoms, cost information analytics used by oncologists and their patients in shared decision-making, quality reporting, and medical home tools for cancer centers.

Elsevier's Clinical Solutions group supports health institutions in improving patient outcomes, reducing clinical errors, and optimising cost and reimbursements. With Via Oncology, Elsevier will continue to broaden its existing portfolio of solutions to create an integrated offering of end-to-end clinical support and active clinical guidance.

UPMC, a $17 billion healthcare provider and insurer affiliated with the University of Pittsburgh, will continue to be a Via Oncology customer. The Via Oncology chief executive officer, chief medical officer and employees will continue working with the company in Pittsburgh. The acquisition is effective immediately and terms of the agreement are not being disclosed.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here to read the original press release.

STORY TOOLS

  • |
  • |

sponsor links

For banner adsĀ click here